UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Relationship between Repeated Sprint Ability and Aerobic Capacity in Professional Soccer Players

TheScientificWorld, 2013-01, Vol.2013 (2013), p.1-5

2013

Volltextzugriff (PDF)

Challenges of drug discovery in novel target space. The discovery and evaluation of PF-3893787: A novel histamine H4 receptor antagonist

Bioorganic & medicinal chemistry letters, 2011-11, Vol.21 (21), p.6596-6602

2011

Volltextzugriff (PDF)

The Metabolism of Lufotrelvir, a Prodrug Investigated for the Treatment of SARS-COV2 in Humans Following Intravenous Administration

Drug metabolism and disposition, 2023-10, Vol.51 (10), p.1419-1427

2023

Volltextzugriff (PDF)

Design and Synthesis of a Pan-Janus Kinase Inhibitor Clinical Candidate (PF-06263276) Suitable for Inhaled and Topical Delivery for the Treatment of Inflammatory Diseases of the Lungs and Skin

Journal of medicinal chemistry, 2017-01, Vol.60 (2), p.767-786

2017

Volltextzugriff (PDF)

Interpretation and prediction of inhaled drug particle accumulation in the lung and its associated toxicity

Xenobiotica, 2012-01, Vol.42 (1), p.86-93

2012

Volltextzugriff (PDF)

Discovery and evaluation of non-basic small molecule modulators of the atypical chemokine receptor CXCR7

Bioorganic & medicinal chemistry letters, 2021-10, Vol.50, p.128320-128320, Article 128320

2021

Volltextzugriff (PDF)

Design and synthesis of long acting inhaled corticosteroids for the treatment of asthma

Bioorganic & medicinal chemistry letters, 2011-10, Vol.21 (19), p.5826-5830

2011

Volltextzugriff (PDF)

Effects of competition on the sleep patterns of elite rugby union players

European journal of sport science, 2015-01, Vol.15 (8), p.681-686

2015

Volltextzugriff (PDF)

Discovery of a Novel Small-Molecule Modulator of C–X–C Chemokine Receptor Type 7 as a Treatment for Cardiac Fibrosis

Journal of medicinal chemistry, 2018-04, Vol.61 (8), p.3685-3696

2018

Volltextzugriff (PDF)

A new methodology for predicting human pharmacokinetics for inhaled drugs from oratracheal pharmacokinetic data in rats

Xenobiotica, 2012-01, Vol.42 (1), p.75-85

2012

Volltextzugriff (PDF)

Inhalation by design: novel ultra-long-acting β(2)-adrenoreceptor agonists for inhaled once-daily treatment of asthma and chronic obstructive pulmonary disease that utilize a sulfonamide agonist headgroup

Journal of medicinal chemistry, 2010-09, Vol.53 (18), p.6640

2010

Volltextzugriff (PDF)

Inhalation by Design: Novel Ultra-Long-Acting β2-Adrenoreceptor Agonists for Inhaled Once-Daily Treatment of Asthma and Chronic Obstructive Pulmonary Disease That Utilize a Sulfonamide Agonist Headgroup

Journal of medicinal chemistry, 2010-09, Vol.53 (18), p.6640-6652

2010

Volltextzugriff (PDF)

Molecular hybridization yields triazole bronchodilators for the treatment of COPD

Bioorganic & medicinal chemistry letters, 2015-11, Vol.25 (22), p.5121-5126

2015

Volltextzugriff (PDF)

Measuring Recovery in Elite Rugby Players: The Brief Assessment of Mood, Endocrine Changes, and Power

Research quarterly for exercise and sport, 2015, Vol.86 (4), p.379-386

2015

Volltextzugriff (PDF)

Inhalation by design: Dual pharmacology β-2 agonists/M3 antagonists for the treatment of COPD

Bioorganic & medicinal chemistry letters, 2011-05, Vol.21 (9), p.2759-2763

2011

Volltextzugriff (PDF)

Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19

Nature communications, 2021-10, Vol.12 (1), p.6055-17, Article 6055

2021

Volltextzugriff (PDF)

Discovery of a series of potent and selective human H4 antagonists using ligand efficiency and libraries to explore structure–activity relationship (SAR)

Bioorganic & medicinal chemistry letters, 2011-11, Vol.21 (21), p.6591-6595

2011

Volltextzugriff (PDF)

Inhaled adenosine A2A receptor agonists for the treatment of chronic obstructive pulmonary disease

Bioorganic & medicinal chemistry letters, 2008-02, Vol.18 (4), p.1284-1287

2008

Volltextzugriff (PDF)

Inhaled adenosine A(2A) receptor agonists for the treatment of chronic obstructive pulmonary disease

Bioorganic & medicinal chemistry letters, 2008-02, Vol.18 (4), p.1284-1287

2008

Volltextzugriff (PDF)

THE METABOLISM OF LUFOTRELVIR, A PRODRUG INVESTIGATED FOR THE TREATMENT OF SARS-COV-2, IN HUMANS FOLLOWING INTRAVENOUS ADMINISTRATION

Drug metabolism and disposition, 2023-07

2023

Volltextzugriff (PDF)

The sulfonamide group as a structural alert: A distorted story?

Current opinion in drug discovery & development, 2008-01, Vol.11 (1), p.72

2008

Volltextzugriff (PDF)

Design and Synthesis of a Pan-Janus Kinase Inhibitor Clinical Candidate (PF-06263276) Suitable for Inhaled and Topical Delivery for the Treatment of Inflammatory Diseases of the Lungs and Skin

Journal of medicinal chemistry, 2016-12, Vol.60 (2)

2016

Volltextzugriff (PDF)

Commentaries on ‘Nonsteroidal anti‐inflammatory drugs and tonsillectomy perioperative bleeding in paediatric tonsillectomy’

Evidence-based child health, 2012-01, Vol.7 (1), p.290-293

2012

Volltextzugriff (PDF)

Inhalation by Design: Novel Ultra-Long-Acting β 2 -Adrenoreceptor Agonists for Inhaled Once-Daily Treatment of Asthma and Chronic Obstructive Pulmonary Disease That Utilize a Sulfonamide Agonist Headgroup

Journal of medicinal chemistry, 2010-09, Vol.53 (18), p.6640-6652

2010

Volltextzugriff (PDF)

1 – 25 von 262

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(222)
Mit Volltextzugriff
(221)

Publikationsform

Sprache

Englisch
(257)
Französisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Relationship between Repeated Sprint Ability and Aerobic Capacity in Professional Soccer Players

An Imidazopiperidine Series of CCR5 Antagonists for the Treatment of HIV: The Discovery of N-{(1S)-1-(3-Fluorophenyl)-3-[(3-endo)-3-(5-isobutyryl-2-methyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-1-yl)-8-azabicyclo[3.2.1]oct-8-yl]propyl}acetamide (PF-232798)

Challenges of drug discovery in novel target space. The discovery and evaluation of PF-3893787: A novel histamine H4 receptor antagonist

The Metabolism of Lufotrelvir, a Prodrug Investigated for the Treatment of SARS-COV2 in Humans Following Intravenous Administration

Design and Synthesis of a Pan-Janus Kinase Inhibitor Clinical Candidate (PF-06263276) Suitable for Inhaled and Topical Delivery for the Treatment of Inflammatory Diseases of the Lungs and Skin

Interpretation and prediction of inhaled drug particle accumulation in the lung and its associated toxicity

Discovery and evaluation of non-basic small molecule modulators of the atypical chemokine receptor CXCR7

Design and synthesis of long acting inhaled corticosteroids for the treatment of asthma

Effects of competition on the sleep patterns of elite rugby union players

Discovery of a Novel Small-Molecule Modulator of C–X–C Chemokine Receptor Type 7 as a Treatment for Cardiac Fibrosis

A new methodology for predicting human pharmacokinetics for inhaled drugs from oratracheal pharmacokinetic data in rats

Inhalation by design: novel ultra-long-acting β(2)-adrenoreceptor agonists for inhaled once-daily treatment of asthma and chronic obstructive pulmonary disease that utilize a sulfonamide agonist headgroup

Inhalation by Design: Novel Ultra-Long-Acting β2-Adrenoreceptor Agonists for Inhaled Once-Daily Treatment of Asthma and Chronic Obstructive Pulmonary Disease That Utilize a Sulfonamide Agonist Headgroup

Molecular hybridization yields triazole bronchodilators for the treatment of COPD

Measuring Recovery in Elite Rugby Players: The Brief Assessment of Mood, Endocrine Changes, and Power

Inhalation by design: Dual pharmacology β-2 agonists/M3 antagonists for the treatment of COPD

Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19

Discovery of a series of potent and selective human H4 antagonists using ligand efficiency and libraries to explore structure–activity relationship (SAR)

Inhaled adenosine A2A receptor agonists for the treatment of chronic obstructive pulmonary disease

Inhaled adenosine A(2A) receptor agonists for the treatment of chronic obstructive pulmonary disease

THE METABOLISM OF LUFOTRELVIR, A PRODRUG INVESTIGATED FOR THE TREATMENT OF SARS-COV-2, IN HUMANS FOLLOWING INTRAVENOUS ADMINISTRATION

The sulfonamide group as a structural alert: A distorted story?

Design and Synthesis of a Pan-Janus Kinase Inhibitor Clinical Candidate (PF-06263276) Suitable for Inhaled and Topical Delivery for the Treatment of Inflammatory Diseases of the Lungs and Skin

Commentaries on ‘Nonsteroidal anti‐inflammatory drugs and tonsillectomy perioperative bleeding in paediatric tonsillectomy’

Inhalation by Design: Novel Ultra-Long-Acting β 2 -Adrenoreceptor Agonists for Inhaled Once-Daily Treatment of Asthma and Chronic Obstructive Pulmonary Disease That Utilize a Sulfonamide Agonist Headgroup

Suchergebnisse filtern